Trials / Unknown
UnknownNCT05434208
Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)
Effects of Nurse-led Telephone Based Service for Early Palliative Care Patients With Advanced Cancer: the Paltel Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non-pharmacological, interventional, two-arm, randomized controlled trial. Early Palliative Care cancer patients will be randomized to active telephonic follow-up program by specialist nurses until end-of-treatment (28 days) (group A, research arm) or face-to-face visit at end of treatment (28 days) (group B, control arm). There are few studies demonstrating the efficacy of nurse-led telephone service in advanced cancer patients but it's still quite unclear how they can affect quality of life, symptom burden and caregivers distress. In addition, the ideal structure, method and timing of telephone follow-up as well are often not considered and have not been articulated. Nurse-led management by phone to advanced cancer patients could, for some patients, dramatically improve their care experience, quality of life and symptoms control. Investigators want to build an effective and sustainable approach for implementing the telephone service providing nurse-led telephone-based support to Early Palliative Care cancer patients. The aim is to investigate the feasibility of a proactive approach and measure the efficacy in terms of symptom management, satisfaction with care and impact on health care resources.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Nurse-led telephonic calls | active telephonic follow-up program by specialist nurses until end-of-treatment (28 days) |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2024-12-01
- Completion
- 2025-09-01
- First posted
- 2022-06-27
- Last updated
- 2022-06-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05434208. Inclusion in this directory is not an endorsement.